Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Jun 16;40(2):119-128.
doi: 10.1055/s-0043-57257. eCollection 2023 Apr.

Medical Management of Peripheral Artery Disease

Affiliations
Review

Medical Management of Peripheral Artery Disease

Alexander E Sullivan et al. Semin Intervent Radiol. .

Abstract

Peripheral artery disease (PAD) is a common type of atherosclerotic disease of the lower extremities associated with reduced quality of life and ambulatory capacity. Major adverse cardiovascular events and limb amputations are the leading cause of morbidity and mortality in this population. Optimal medical therapy is therefore critical in these patients to prevent adverse events. Risk factor modifications, including blood pressure control and smoking cessation, in addition to antithrombotic agents, peripheral vasodilators, and supervised exercise therapy are key pillars of medical therapy. Revascularization procedures represent key touch points between patients and health care providers and serve as opportunities to optimize medical therapy and improve long-term patency rates and outcomes. This review summarizes the aspects of medical therapy that all providers should be familiar with when caring for patients with PAD in the peri-revascularization period.

Keywords: antithrombotic therapy; interventional radiology; medical management; peripheral artery disease; smoking cessation; supervised exercise therapy.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest A.E.S. is supported by the National Institute of General Medical Science of the National Institutes of Health under award number T32 GM007569. J.A.B.: Consulting—Janssen, Novartis, JanOne. Research—Bristol Myers Squibb.

Figures

Fig. 1
Fig. 1
Postoperative guide for medical optimization of patients with peripheral artery disease after revascularization. BP, blood pressure; DM, diabetes mellitus; MACE, major adverse cardiovascular events; MALE, major adverse limb events.
Fig. 2
Fig. 2
Key components of medical management for peripheral artery disease.

References

    1. Gerhard-Herman M D, Gornik H L, Barrett C. 2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2017;69(11):1465–1508. - PubMed
    1. Wu A, Coresh J, Selvin E. Lower extremity peripheral artery disease and quality of life among older individuals in the community. J Am Heart Assoc. 2017;6(01):6. - PMC - PubMed
    1. Gutierrez J A, Mulder H, Jones W S. Polyvascular disease and risk of major adverse cardiovascular events in peripheral artery disease: a secondary analysis of the EUCLID trial. JAMA Netw Open. 2018;1(07):e185239. - PMC - PubMed
    1. Berger J S, Ladapo J A. Underuse of prevention and lifestyle counseling in patients with peripheral artery disease. J Am Coll Cardiol. 2017;69(18):2293–2300. - PMC - PubMed
    1. Singh N, Ding L, Devera J, Magee G A, Garg P K. Prescribing of statins after lower extremity revascularization procedures in the US. JAMA Netw Open. 2021;4(12):e2136014. - PMC - PubMed